MCID: ACS001
MIFTS: 58

Acoustic Neuroma malady

Categories: Rare diseases, Neuronal diseases, Cancer diseases

Aliases & Classifications for Acoustic Neuroma

About this section
Sources:
11Disease Ontology, 13DISEASES, 27GTR, 31ICD10 via Orphanet, 38MedlinePlus, 39MeSH, 45NCIt, 48NIH Rare Diseases, 50Novoseek, 54Orphanet, 62SNOMED-CT, 68UMLS, 69UMLS via Orphanet
See all MalaCards sources

Aliases & Descriptions for Acoustic Neuroma:

Name: Acoustic Neuroma 11 48 54 38 13 68
Vestibular Schwannoma 11 48 54 27
Cerebellopontine Angle Tumor 48 68
Acoustic Neurilemoma 48 54
Acoustic Neurinoma 48 54
 
Neurinoma of the Acoustic Nerve 48
Vestibular Neurilemmoma 11
Neuroma, Acoustic 39
Neuroma Acoustic 50
Acoustic Tumor 48

Characteristics:

Orphanet epidemiological data:

54
acoustic neuroma:
Prevalence: 1-9/100000 (Denmark),1-9/100000 (United States),1-9/1000000

Classifications:



External Ids:

Disease Ontology11 DOID:12689
MeSH39 D009464
NCIt45 C3276
Orphanet54 ORPHA252175
UMLS via Orphanet69 C0027859
ICD10 via Orphanet31 D33.3

Summaries for Acoustic Neuroma

About this section
MedlinePlus:38 An acoustic neuroma is a benign tumor that develops on the nerve that connects the ear to the brain. the tumor usually grows slowly. as it grows, it presses against the hearing and balance nerves. at first, you may have no symptoms or mild symptoms. they can include loss of hearing on one side ringing in ears dizziness and balance problems the tumor can also eventually cause numbness or paralysis of the face. if it grows large enough, it can press against the brain, becoming life-threatening. acoustic neuroma can be difficult to diagnose, because the symptoms are similar to those of middle ear problems. ear exams, hearing tests, and scans can show if you have it. if the tumor stays small, you may only need to have it checked regularly. if you do need treatment, surgery and radiation are options. if the tumors affect both hearing nerves, it is often because of a genetic disorder called neurofibromatosis. nih: national institute on deafness and communication disorders

MalaCards based summary: Acoustic Neuroma, also known as vestibular schwannoma, is related to cerebellopontine angle tumor and neurofibromatosis, and has symptoms including back pain, coughing and headache. An important gene associated with Acoustic Neuroma is NF2 (Neurofibromin 2), and among its related pathways are BARD1 signaling events and Spinal Cord Injury. Affiliated tissues include brain, testes and bone, and related mouse phenotypes are Increased cell death in breast cancer cell lines (MCF10A, MDA-MB-435) and Synthetic lethal with MLN4924 (a NAE inhibitor).

Wikipedia:71 A vestibular schwannoma is a benign primary intracranial tumor of the myelin-forming cells of the... more...

Related Diseases for Acoustic Neuroma

About this section

Graphical network of the top 20 diseases related to Acoustic Neuroma:



Diseases related to acoustic neuroma

Symptoms & Phenotypes for Acoustic Neuroma

About this section

UMLS symptoms related to Acoustic Neuroma:


back pain, coughing, headache, pain, sciatica, seizures, snoring, syncope, tremor, chronic pain, sore throat, vertigo/dizziness, equilibration disorder, sleeplessness

GenomeRNAi Phenotypes related to Acoustic Neuroma according to GeneCards Suite gene sharing:

26
idDescriptionGenomeRNAi Source AccessionScoreTop Affiliating Genes
1GR00104-A-010.1MSH2, NBN, PCNA
2GR00250-A-18.4AQP1, LIG1, NBN, PCNA, TGFB1
3GR00250-A-38.2LIG1, MGMT, MSH2, NBN, PARP1, PCNA

MGI Mouse Phenotypes related to Acoustic Neuroma according to GeneCards Suite gene sharing:

41
idDescriptionMGI Source AccessionScoreTop Affiliating Genes
1MP:00053899.0ABCA2, AQP1, NBN, NF2, PARP1, PCNA
2MP:00036318.4ABCA2, AQP1, AQP4, MSH2, NBN, NF2
3MP:00020068.4LIG1, MGMT, MSH2, NBN, NF2, TGFB1
4MP:00053797.9AQP1, AQP4, LIG1, MGMT, NBN, NF2
5MP:00053877.4AQP4, ERCC5, LIG1, MSH2, NBN, NF2
6MP:00053977.4AQP1, AQP4, ERCC5, LIG1, MSH2, NBN
7MP:00053787.3ABCA2, AQP1, AQP4, ERCC5, LIG1, NBN
8MP:00053766.5ABCA2, AQP1, AQP4, ERCC5, LIG1, MGMT
9MP:00107686.1ABCA2, AQP1, AQP4, ERCC5, LIG1, MGMT

Drugs & Therapeutics for Acoustic Neuroma

About this section

Drugs for Acoustic Neuroma (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show top 50)    (show all 62)
idNameStatusPhaseClinical TrialsCas NumberPubChem Id
1Anti-Bacterial AgentsPhase 4, Phase 2, Early Phase 111226
2GentamicinsPhase 4140
3Anti-Infective AgentsPhase 4, Phase 2, Early Phase 122062
4
Prednisoloneapproved, vet_approvedPhase 3119350-24-85755
Synonyms:
(11beta)-11,17,21-Trihydroxypregna-1,4-diene-3,20-dione
.DELTA.1-Cortisol
.DELTA.1-Dehydrocortisol
.DELTA.1-Dehydrohydrocortisone
.DELTA.1-Hydrocortisone
.delta.-Cortef
.delta.-Stab
1,2-Dehydrohydrocortisone
1,4-Pregnadiene-11beta,17alpha,21-triol-3,20-dione
1,4-Pregnadiene-3,20-dione-11beta,17alpha,21-triol
1-Dehydrocortisol
1-Dehydrohydrocortisone
3,20-dioxo-11beta,17alpha,21-Trihydroxy-1,4-pregnadiene
46656_FLUKA
46656_RIEDEL
50-24-8
58201-11-9
8056-11-9
AC-1773
AC1L1L2E
Ak-Pred
Ak-Tate
Alphadrol
Articulose-50
BPBio1_000164
BRD-K98039984-001-03-0
BRN 1354103
BSPBio_000148
Bio-0666
Bubbli-Pred
C07369
CCRIS 980
CHEBI:8378
CHEMBL131
CID5755
CO-Hydeltra
CPD000718761
Co-Hydeltra
Codelcortone
Cordrol
Cortalone
Cotogesic
Cotolone
D00472
D011239
DB00860
Decaprednil
Decortin H
Delcortol
Delta F
Delta(1)-dehydrohydrocortisone
Delta-Cortef
Delta-Cortef (TN)
Delta-Ef-Cortelan
Delta-Stab
Delta-stab
Deltacortenol
Deltacortril
Deltacortril Enteric
Deltahydrocortisone
Deltasolone
Deltisilone
Depo-Medrol
Derpo PD
Derpo Pd
Dexa-Cortidelt Hostacortin H
Dexa-Cortidelt hostacortin H
Di Adreson F
Di-Adreson F
Di-Adreson-F
Di-adreson F
DiAdresonF
Dicortol
Donisolone
Dydeltrone
EINECS 200-021-7
Eazolin D
Econopred
Econopred Plus
Erbacort
Erbasona
Estilsona
Fernisolone
Fernisolone P
Fernisolone-P
Flamasone
HMS1568H10
HMS2090J05
HSDB 3385
Hostacortin H
Hydeltra
Hydeltra-Tba
Hydeltrasol
Hydeltrone
Hydrodeltalone
Hydrodeltisone
Hydroretrocortin
Hydroretrocortine
I-Pred
Inflamase Forte
Inflamase Mild
K 1557
Key-Pred
Klismacort
LMST02030179
LS-7669
Lentosone
Lite Pred
M-Predrol
 
MLS001304083
MLS002154250
MLS002207037
Medrol
Medrol Acetate
Metacortandralone
Methylprednisolone Acetate
Meti-Derm
Meticortelone
Metreton
MolPort-002-507-147
NCGC00179649-01
NSC 9120
NSC9120
NSC9900
Neo-Delta-Cortef
Nisolone
Nor-Pred T.B.A.
Ocu-Pred
Ocu-Pred Forte
Ophtho-Tate
Orapred
P0152_SIGMA
P0637
P6004_SIGMA
PRDL
PRED-G
Panafcortelone
Paracortol
Paracotol
Pediapred
Poly-Pred
Precortalon
Precortancyl
Precortilon
Precortisyl
Pred Forte
Pred Mild
Predair
Predair A
Predair Forte
Predalone 50
Predalone T.B.A.
Predate
Predate Tba
Predate-50
Predcor-25
Predcor-50
Predcor-Tba
Predisolone Sodium Phosphate
Predne-Dome
Prednelan
Predni-Dome
Prednicen
Predniliderm
Predniretard
Prednis
Prednisolona
Prednisolona [INN-Spanish]
Prednisolone (JP15/USP/INN)
Prednisolone (anhydrous)
Prednisolone Acetate
Prednisolone Sodium Phosphate
Prednisolone Tebutate
Prednisolone [INN:BAN:JAN]
Prednisolonum
Prednisolonum [INN-Latin]
Predonin
Predonine
Prelone
Prenolone
Prestwick0_000274
Prestwick1_000274
Prestwick2_000274
Prestwick3_000274
Prestwick_404
Rolisone
S1737_Selleck
SAM002264639
SMR000718761
SPBio_002367
Scherisolon
Solone
Steran
Sterane
Sterolone
Supercortisol
UNII-9PHQ9Y1OLM
Ulacort
Ultra Pred
Ultracorten H
Ultracortene H
Ultracortene-H
Ultracortene-Hydrogen
Ultracortene-hydrogen
ZINC03833821
component of Ataraxoid
component of K-Predne-Dome
delta(1)-Cortisol
delta(1)-Dehydrocortisol
delta(1)-Dehydrohydrocortisone
delta(1)-Hydrocortisone
delta(sup 1)-Cortisol
delta(sup 1)-Dehydrocortisol
delta(sup 1)-Dehydrohydrocortisone
delta(sup 1)-Hydrocortisone
delta-dehydrocortisol
delta-dehydrohydrocortisone
delta-hydrocortisone
prednisolone
5
Methylprednisoloneapproved, vet_approvedPhase 3119383-43-26741
Synonyms:
(6S,8S,9S,10R,11S,13S,14S,17R)-11,17-dihydroxy-17-(2-hydroxyacetyl)-6,10,13-trimethyl-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-3-one
(6a,11b)-11,17,21-Trihydroxy-6-methylpregna-1,4-diene-3,20-dione
(6alpha,11beta)-11,17,21-Trihydroxy-6-methylpregna-1,4-diene-3,20-dione
(6α,11β)-11,17,21-trihydroxy-6-methylpregna-1,4-diene-3,20-dione
.DELTA.1-6.alpha.-Methylhydrocortisone
1-Dehydro-6alpha-methylhydrocortisone
1-dehydro-6alpha-Methylhydrocortisone
1-dehydro-6α-methylhydrocortisone
11-beta,17,21-Trihydroxy-6-alpha-methylpregna-1,4-diene-3,20-dione
11beta,17,21-Trihydroxy-6alpha-methylpregna-1,4-diene-3,20-dione
11beta,17alpha,21-Trihydroxy-6alpha-methyl-1,4-pregnadiene-3,20-dione
11beta,17alpha,21-Trihydroxy-6alpha-methylpregna-1,4-diene-3,20-dione
121673-01-6
4-08-00-03498 (Beilstein Handbook Reference)
46436_FLUKA
46436_RIEDEL
570-35-4
6 Methylprednisolone
6-Methylprednisolone
6-alpha-Methylprednisolone
6.alpha.-Methylprednisolone
6923-42-8
6alpha-Methyl-11beta,17alpha,21-trihydroxy-1,4-pregnadiene-3,20-dione
6alpha-Methyl-11beta,17alpha,21-triol-1,4-pregnadiene-3,20-dione
6alpha-Methylprednisolone
6alpha-methyl-11beta,17alpha,21-triol-1,4-pregnadiene-3,20-dione
83-43-2
AC1L1N7A
Artisone-Wyeth
Artisone-wyeth
BPBio1_000174
BRD-K35240538-001-03-1
BRN 2340300
BSPBio_000158
Besonia
Bio-0658
CHEBI:6888
CHEMBL650
CID6741
CPD000058330
D00407
D008775
DB00959
Depo-Medrol (acetate)
Dopomedrol
EINECS 201-476-4
Esametone
Firmacort
HMS1568H20
HMS2090B13
HSDB 3127
LMST02030178
LS-118498
Lemod
M0639_SIGMA
M1665
MEPRDL
MLS000028541
MLS001148159
MLS002207191
Medesone
Medixon
Medlone 21
 
Medrate
Medrol
Medrol (TN)
Medrol Adt Pak
Medrol Dosepak
Medrol adt pak
Medrol dosepak
Medrol, Solu-Medrol, Medrone, Methylprednisolone
Medrone
Mesopren
Metastab
Methyleneprednisolone
Methylprednisolon
Methylprednisolone
Methylprednisolone (JP15/USP/INN)
Methylprednisolone [USAN:INN:BAN:JAN]
Methylprednisolone, 6-alpha
Methylprednisolonum
Methylprednisolonum [INN-Latin]
Metilbetasone
Metilprednisolona
Metilprednisolona [INN-Spanish]
Metilprednisolone
Metilprednisolone [DCIT]
Metilprednisolone [Dcit]
Metipred
Metrisone
Metrocort
Metysolon
Moderin
MolPort-002-528-554
NCGC00022735-03
NCI60_001657
NSC-19987
NSC19987
Nirypan
Noretona
Predni N Tablinen
Prednol- L
Pregna-1,4-diene-3,20-dione, 11beta,17,21-trihydroxy-6alpha-methyl- (8CI)
Prestwick0_000279
Prestwick1_000279
Prestwick2_000279
Prestwick3_000279
Prestwick_622
Promacortine
Reactenol
S1733_Selleck
SAM002589984
SMR000058330
SPBio_002377
Sieropresol
Solomet
Summicort
Suprametil
U 7532
UNII-X4W7ZR7023
Urbason
Urbasone
Wyacort
ZINC03875560
delta(1)-6alpha-Methylhydrocortisone
delta(sup 1)-6-alpha-Methylhydrocortisone
methylprednisolone
methylprenisolone
6Anti-Inflammatory AgentsPhase 3, Phase 210729
7Peripheral Nervous System AgentsPhase 3, Phase 223689
8Neuroprotective AgentsPhase 31716
9Prednisolone acetatePhase 31193
10Prednisolone hemisuccinatePhase 31193
11AntiemeticsPhase 34022
12Protective AgentsPhase 37443
13Prednisolone phosphatePhase 31193
14Antineoplastic Agents, HormonalPhase 35592
15Methylprednisolone HemisuccinatePhase 31193
16glucocorticoidsPhase 35103
17Gastrointestinal AgentsPhase 38402
18Autonomic AgentsPhase 310150
19Methylprednisolone acetatePhase 31193
20Hormone AntagonistsPhase 313180
21HormonesPhase 314415
22Hormones, Hormone Substitutes, and Hormone AntagonistsPhase 313168
23
Bevacizumabapproved, investigationalPhase 2, Phase 12020216974-75-3
Synonyms:
216974-75-3
Avastin
Avastin (TN)
Bevacizumab
Bevacizumab (genetical recombination)
 
Bevacizumab (genetical recombination) (JAN)
D06409
R-435
anti-VEGF monoclonal antibody
antiVEGF
bevacizumab
24
Sirolimusapproved, investigationalPhase 2, Early Phase 1194053123-88-95284616, 6436030, 46835353
Synonyms:
(-)-Rapamycin
(-)-rapamycin
1fkb
1pbk
23,27-Epoxy-3H-pyrido(2,1-c)(1,4)oxaazacyclohentriacontine
23,27-Epoxy-3H-pyrido[2,1-c][1,4]oxaazacyclohentriacontine
23,27-epoxy-3H-pyrido[2,1-c][1,4]oxaazacyclohentriacontine-1,5,11,28,29
3H-pyrido(2,1-c)(1,4)oxaazacyclohentriacontine-1,5,11,28,29(4H,6H,31H)-pentone
53123-88-9
A422989, NSC226080
AC-722
AC1L1JH9
AC1L7MJ9
AC1L9ZMV
AY 22989
AY-22989
AY22989
Ambotz53123-88-9
Antibiotic AY 22989
BIDD:PXR0165
Bio1_000293
Bio1_000782
Bio1_001271
Bio2_000375
Bio2_000855
BiomolKI2_000084
C07909
C51H79NO13
CBiol_002007
CCRIS 9024
CHEBI:100923
CHEBI:9168
CHEMBL413
CID10213190
CID10795871
CID11949238
CID11959112
CID313006
CID478951
CID5040
CID5284616
CID5358081
CID5374464
CID5460439
CID5497196
CID5924240
CID6436030
CID6610270
CID6610346
CID6711160
CID6713081
CID9833581
CID9854379
CID9854380
CID9962926
CID9962928
D00753
DB00877
DE-109
DivK1c_006936
 
FT-0082351
HMS2089A21
HSDB 7284
KBio1_001880
KBio2_000410
KBio2_002978
KBio2_005546
KBio3_000779
KBio3_000780
KBioGR_000410
KBioSS_000410
LCP-Siro
LMPK06000003
LS-143290
MLS000028373
MS-R001
MolMap_000043
MolPort-003-959-433
NCGC00021305-05
NCI60_001851
NCIMech_000355
NSC 226080
NSC226080
Perceiva
QTL1_000069
R0395_SIAL
R0395_SIGMA
RAP
RAPA
RPM
Rapammune
Rapamune
Rapamune (TN)
Rapamycin
Rapamycin (TN)
Rapamycin C-7, analog 4
Rapamycin Immunosuppressant Drug
Rapamycin from Streptomyces hygroscopicus
S1039_Selleck
SIIA 9268A
SILA 9268A
SILA9268A
SMP1_000255
SMR000058564
Sirolimus
Sirolimus (RAPAMUNE)
Sirolimus (USAN/INN)
Sirolimus [USAN:BAN:INN]
Sirolimus, Rapamune,Rapamycin
SpecPlus_000840
UNII-W36ZG6FT64
UNM-0000358684
WY-090217
Wy 090217
heptadecahydro-9,27-dihydroxy-3-[(1R)-2-[(1S,3R,4R)-4-hydroxy
nchembio.100-comp4
nchembio.2007.42-comp2
nchembio.79-comp1
nchembio762-comp1
nchembio883-comp3
rapamycin
sirolimus
25
Miconazoleapproved, investigational, vet_approvedPhase 2, Early Phase 1370622916-47-84189
Synonyms:
(+-)-1-(2,4-Dichloro-beta-((2,4-dichlorobenzyl)oxy)phenethyl)imidazole
1-(2,4-Dichloro-beta-((2,4-dichlorobenzyl)oxy)phenethyl)imidazole
1-(2,4-dichloro-beta-((2,4-dichlorobenzyl)oxy)phenethyl) imidazole
1-[2,4-Dichloro- beta-([2,4-dichloro- benzyl]oxy)phenethyl]imidazole
1-[2-(2,4-Dichloro-benzyloxy)-2-(2,4-dichloro-phenyl)-ethyl]-1H-imidazole
1-[2-(2,4-Dichlorophenyl)-2-[(2,4-dichlorophenyl)methoxy]ethyl]-1H-imidazole
1-[2-(2,4-dichlorobenzyloxy)-2-(2,4-dichlorophenyl)ethyl]-1H-imidazole
1-[2-(2,4-dichlorophenyl)-2-[(2,4-dichlorophenyl)methoxy]ethyl]imidazole
1-[2-(2,4-dichlorophenyl)-2-{[(2,4-dichlorophenyl)methyl]oxy}ethyl]-1H-imidazole
1-{2-[(2,4-dichlorobenzyl)oxy]-2-(2,4-dichlorophenyl)ethyl}-1H-imidazole
22832-87-7 (NITRATE)
22916-47-8
75319-47-0
AB00053500
AC1L1HM1
AKOS001574474
Aflorix(nitrate)
Albistat(nitrate)
Andergin(nitrate)
BPBio1_000279
BRD-A82396632-001-03-0
BRD-A82396632-008-02-7
BRN 0965511
BSPBio_000253
BSPBio_002033
CCRIS 7924
CHEBI:6923
CHEMBL91
CID4189
CPD-4501
Conofite(nitrate)
D00416
DB01110
Dactarin
Daktarin IV
Daktarin iv
DivK1c_000156
EINECS 245-324-5
Epi-Monistat(nitrate)
Femizol-M
Florid(nitrate)
Gyno-Daktar(nitrate)
HMS1568M15
HMS2090B21
I14-14342
IDI1_000156
Imidazole, 1-(2-(2,4-dichlorophenyl)-2-((2,4-dichlorophenyl)methoxy)ethyl)- (9CI)
KBio1_000156
KBio2_001445
KBio2_004013
KBio2_006581
KBio3_001533
KBioGR_000581
KBioSS_001445
LS-78378
Lotrimin AF(nitrate)
MCZ
MJR 1762
MLS002222203
Micantin (nitrate)
Miconasil Nitrate
 
Miconazol
Miconazol [INN-Spanish]
Miconazole
Miconazole (JP15/USP/INN)
Miconazole 3
Miconazole 3 Combination Pack
Miconazole 7 Combination Pack
Miconazole [USAN:BAN:INN:JAN]
Miconazole nitrate salt
Miconazole-7
Miconazolo
Miconazolo [DCIT]
Miconazolum
Miconazolum [INN-Latin]
Micozole
Minostate
MolPort-002-557-553
Monazole 7
Monista (nitrate)
Monistat
Monistat (TN)
Monistat 1 Combination Pack
Monistat 3 Dual-Pak
Monistat 3 Vaginal Ovules
Monistat 5 Tampon
Monistat 7 Dual-Pak
Monistat 7 Vaginal Suppositories
Monistat Dual- PAK
Monistat IV
Monistat iv (TN)
Monistat iv (tn)
Monistat-Derm
NCI60_001353
NCI60_001380
NINDS_000156
NSC 170986
NSC169434
NSC170986
Novo-Miconazole Vaginal Ovules
Oprea1_091955
Prestwick0_000067
Prestwick1_000067
Prestwick2_000067
Prestwick3_000067
Prestwick_335
R 18134
R-14,889
SMR001307249
SPBio_000976
SPBio_002174
STK834405
STOCK1S-93556
Spectrum2_001048
Spectrum3_000507
Spectrum4_000061
Spectrum5_001297
Spectrum_000965
UNII-7NNO0D7S5M
Vusion
Zimycan
imidazole, 1-(2-(2,4-dichlorophenyl)-2-((2,4-dichlorophenyl) methoxy)ethyl)- (9CI)
miconazole
26
EverolimusapprovedPhase 2, Early Phase 11940159351-69-66442177
Synonyms:
(1R,9S,12S,15R,16E,18R,19R,21R,23S,24E,26E,28E,30S,32S,35R)-1,18-Dihydroxy-12-((1R)-2-((1S,3R,4R)-4-(2-hydroxyethoxy)-3-methoxycyclohexyl)-1-methylethyl)-19,30-dimethoxy-15,17,21,23,29,35-hexamethyl-11,36-dioxa-4-azatricyclo(30.3.1.0(sup 4,9))hexatriaconta-16,24,26,28-tetraene-2,3,10,14,20-pentaone
(1R,9S,12S,15R,16E,18R,19R,21R,23S,24E,26E,28E,30S,32S,35R)-1,18-Dihydroxy-12-((1R)-2-((1S,3R,4R)-4-(2-hydroxyethoxy)-3-methoxycyclohexyl)-1-methylethyl)-19,30-dimethoxy-15,17,21,23,29,35-hexamethyl-11,36-dioxa-4-azatricyclo(30.3.1.04,9)hexatriaconta-16,24,26,28-tetraene-2,3,10,14,20-pentaone
(1R,9S,12S,15R,16E,23S,18R,19R,21R,23S,24E,26E,28E,30S,32S,35R)-1,18-dihydroxy-12-((1R)-2-((1S,3R,4R)-4-(2-hydroxyethoxy)-3-methoxycyclohexyl)-1-methylethyl)-19,30-dimethoxy-15,17,21,23,29,35-hexamethyl-11,36-dioxa-4-azatricyclo(30.3.1.0(sup 4,9))hexatriacont
(3S,6R,7E,9R,10R,12R,14S,15E,17E,19E,21S,23S,26R,27R,34aS)-9,10,12,13,14,21,22,23,24,25,26,27,32,33,34,34a-Hexadecahydro-9,27-dihydroxy-3-((1R)-2-((1S,3R,4R)-4-(2-hydroxyethoxy)-3-methoxycyclohexyl)-1-methylethyl)-10,21-dimethoxy-6,8,12,14,20,26-hexamethyl-23,27-epoxy-3H-pyrido(2,1-c)(1,4)oxaazacyclohentriacontine-1,5,11,28,29(4H,6H,31H)-pentone
(3S,6R,7E,9R,10R,12R,14S,15E,17E,19E,21S,23S,26R,27R,34aS)-9,27-dihydroxy-3-{(2R)-1-[(1S,3R,4R)-4-(2-hydroxyethoxy)-3-methoxycyclohexyl]propan-2-yl}-10,21-dimethoxy-6,8,12,14,20,26-hexamethyl-9,10,12,13,14,21,22,23,24,25,26,27,32,33,34,34a-hexadecahydro-3H-23,27-epoxypyrido[2,1-c][1,4]oxazacyclohentriacontine-1,5,11,28,29(4H,6H,31H)-pentone
(3S,6R,7E,9R,10R,12R,14S,15E,17E,19E,21S,23S,26R,27R,34as)-9,10,12,13,14,21,22,23,24,25,26,27,32,33,34,34a-hexadecahydro-9,27-dihydroxy-3-((1R)-2-((1S,3R,4R)-4-(2-hydroxyethoxy)-3-methoxycyclohexyl)-1-methylethyl)-10,21-dimethoxy-6,8,12,14,20,26-hexamethy
07741_FLUKA
159351-69-6
40-O-(2-hydroxyethyl)-rapamycin
42-O-(2-Hydroxyethyl)rapamycin
Afinitor
CERTICAN(R)
CHEMBL1201755
Certican
D02714
DB01590
 
Everolimus
Everolimus (JAN/USAN/INN)
Everolimus [USAN]
LS-143292
MolPort-003-847-342
MolPort-003-925-588
NCGC00167512-01
NVP-RAD-001
RAD 001
RAD-001
RAD-001C
RAD001
RAD001, SDZ-RAD, Certican, Zortress, Afinitor, Everolimus
S1120_Selleck
SDZ-RAD
UNII-9HW64Q8G6G
Zortress
everolimus
27
Axitinibapproved, investigationalPhase 2109319460-85-06450551
Synonyms:
319460-85-0
790713-39-2
AC-1539
AC1O51X3
AG 013736
AG-013736
AG-013736, Axitinib
AG-13736
AG013736
Axitinib
C503983
CID6450551
 
EC-000.2322
I14-1971
INLYTA
Inlyta
MolPort-006-392-413
N-methyl-2-((3-((1E)-2-(pyridin-2-yl)ethenyl)-1H-indazol-6-yl)sulfanyl)benzamide
N-methyl-2-[[3-[(E)-2-pyridin-2-ylethenyl]-1H-indazol-6-yl]sulfanyl]benzamide
S1005_Selleck
ST51054130
UNII-C9LVQ0YUXG
ZINC03816287
axitinib
axitinibum
28
Aspirinapproved, vet_approvedPhase 2115250-78-22244
Synonyms:
11126-35-5
11126-37-7
1oxr
2-(Acetyloxy)benzoate
2-(Acetyloxy)benzoic acid
2-Acetoxybenzenecarboxylic acid
2-Acetoxybenzoate
2-Acetoxybenzoic acid
2-Carboxyphenyl acetate
2349-94-2
26914-13-6
50-78-2
8-hour Bayer
98201-60-6
A 5376
A.S.A
A.S.A.
A.S.A. Empirin
A.S.A. empirin
A2093_SIGMA
A3160_SIGMA
A5376_SIGMA
A6810_SIGMA
AB1003266
AC 5230
AC1L1D8U
AC1Q1LA0
ACETYLSALICYLIC ACID
AI3-02956
AIN
AKOS000118884
ASA
Acenterine
Acesal
Acetal
Acetard
Aceticyl
Acetilsalicilico
Acetilum acidulatum
Acetisal
Acetol
Acetonyl
Acetophen
Acetosal
Acetosalic acid
Acetosalin
Acetoxybenzoic acid
Acetylin
Acetylsal
Acetylsalicylate
Acetylsalicylic acid
Acetylsalicylsaeure
Acetylsalicylsaure
Acetylsalicylsäure
Acetylsalycilic acid
Acetyonyl
Acetysal
Acetysalicylic acid
Acide acetylsalicylique
Acido O-acetil-benzoico
Acido acetilsalicilico
Acidum acetylsalicylicum
Acimetten
Acisal
Acylpyrin
Adiro
Aloxiprimum
Asacard
Asagran
Asatard
Ascoden-30
Aspalon
Aspec
Aspergum
Aspir-Mox
Aspirdrops
Aspirin
Aspirin (JP15/USP)
Aspirin [BAN:JAN]
Aspirina 03
Aspirine
Asprin
Aspro
Aspro Clear
Asteric
Azetylsalizylsaeure
Azetylsalizylsäure
BIDD:GT0118
BRN 0779271
Bay-e-4465
Bayer
Bayer Aspirin 8 Hour
Bayer Buffered
Bayer Extra Strength Aspirin For Migraine Pain
Bayer Plus
Benaspir
Bi-prin
Bialpirina
Bialpirinia
Bufferin
C01405
CCRIS 3243
CHEBI:15365
CHEMBL25
CID2244
Caprin
Cardioaspirin
Cardioaspirina
Cemirit
Claradin
Clariprin
Colfarit
Contrheuma retard
Coricidin
Crystar
D00109
D001241
DB00945
Decaten
Delgesic
Dispril
DivK1c_000555
Dolean pH 8
Duramax
ECM
EINECS 200-064-1
EU-0100038
Easprin
Easprin (TN)
Ecolen
Ecotrin
Empirin
Empirin with Codeine
Endosprin
Endydol
Entericin
Enterophen
 
Enterosarein
Enterosarine
Entrophen
Extren
Globentyl
Globoid
HMS1920E13
HMS2090G03
HMS2091K13
HMS501L17
HSDB 652
Helicon
I14-7505
IDI1_000555
Idragin
Istopirin
KBio1_000555
KBio2_001725
KBio2_002271
KBio2_004293
KBio2_004839
KBio2_006861
KBio2_007407
KBio3_002149
KBio3_002751
KBioGR_000398
KBioGR_002271
KBioSS_001725
KBioSS_002272
Kapsazal
Kyselina 2-acetoxybenzoova
Kyselina acetylsalicylova
LS-143
Levius
Lopac-A-5376
Lopac0_000038
MLS001055329
MLS001066332
MLS001336045
MLS001336046
Magnecyl
Measurin
Medisyl
Micristin
MolPort-000-871-622
NCGC00015067-01
NCGC00015067-04
NCGC00015067-09
NCGC00090977-01
NCGC00090977-02
NCGC00090977-03
NCGC00090977-04
NCGC00090977-05
NCGC00090977-06
NCGC00090977-07
NCI60_002222
NINDS_000555
NSC 27223
NSC27223
NSC406186
Neuronika
Novid
Nu-seals
Nu-seals aspirin
O-(Acetyloxy)benzoate
O-(Acetyloxy)benzoic acid
O-Acetoxybenzoate
O-Acetoxybenzoic acid
O-Acetylsalicylic acid
O-Carboxyphenyl acetate
O-accetylsalicylic acid
O-acetylsalicylic acid
PL-2200
Persistin
Pharmacin
Pirseal
Polopirin
Polopiryna
Premaspin
R16CO5Y76E [UNII]
Rheumin tabletten
Rheumintabletten
Rhodine
Rhonal
Ronal
S-211
SMR000059138
SP 189
SPBio_001838
SPECTRUM1500130
ST075414
Salacetin
Salcetogen
Saletin
Salicylic acid acetate
Salicylic acid, acetate
Salospir
Solfrin
Solprin
Solprin acid
Solpyron
Solupsan
Spectrum2_001899
Spectrum3_001295
Spectrum4_000099
Spectrum5_000740
Spectrum_001245
Spira-Dine
St. Joseph
St. Joseph Aspirin for Adults
Supac
Tasprin
Temperal
Toldex
Triaminicin
Triple-sal
UNII R16CO5Y76E
UNII-R16CO5Y76E
UNII=R16CO5Y76E
UNM-0000306102
Vanquish
WLN: QVR BOV1
XAXA
Xaxa
Yasta
ZORprin
acide 2-(acétyloxy)benzoïque
acide acétylsalicylique
aspirin
cMAP_000006
component of Midol
component of Synirin
nchem.859-comp6
o-Acetoxybenzoic acid
o-Carboxyphenyl acetate
o-acetoxybenzoic acid
o-carboxyphenyl acetate
salicylic acid acetate
ácido acetilsalicílico
29
Lapatinibapproved, investigational, Approved March 2007Phase 2, Early Phase 1301231277-92-2, 388082-78-8208908, 9941095
Synonyms:
1xkk
231277-92-2
388082-78-8
4-[[3-Chloro-4-(3-fluorobenzyloxy)phenyl]amino]-6-[5-[[(2-methanesulfonylethyl)amino]methyl]furan-2-yl]quinazoline
AB1004631
AC-1314
AC1L4LL4
AKOS005145766
CHEBI:49603
CHEMBL1201179
CHEMBL554
CID11557040
CID208908
D04024
D08108
DB01259
DB02584
EN002712
FMM
GSK 572016
GSK572016
GW 572016
GW 572016X
GW-2016
GW-572016
GW-572016F
GW2016
GW572016
HMS2089H10
I01-1247
 
Kinome_3684
Kinome_3685
LAPATINIB DITOSYLATE MONOHYDRATE
LS-187029
LS-187771
Lapatinib
Lapatinib (INN)
Lapatinib Ditosylate
Lapatinib [INN]
Lapatinib ditosylate
Lapatinib ditosylate (USAN)
Lapatinib tosilate hydrate
Lapatinib tosilate hydrate (JAN)
Lapatinib, Tykerb, GW572016
N-(3-Chloro-4-((3-fluorophenyl)methoxy)phenyl)-6-(5-((2-methylsulfonylethylamino)methyl)-2-furyl)quinazolin-4-amine
N-(3-Chloro-4-{[(3-fluorophenyl)methyl]oxy}phenyl)-6-[5-({[2-(methylsulfonyl)ethyl]amino}methyl)-2-furanyl]-4-quinazolinamine
N-(3-chloro-4-((3-Fluorophenyl)methoxy)phenyl)-6-(5-(((2-(methylsulfonyl)ethyl)amino)methyl)-2-furanyl)-4-quinazolinamine
N-[3-chloro-4-[(3-fluorophenyl)methoxy]phenyl]-6-[5-[(2-methylsulfonylethylamino)methyl]furan-2-yl]quinazolin-4-amine
N-{3-CHLORO-4-[(3-FLUOROBENZYL)OXY]PHENYL}-6-[5-({[2-(METHYLSULFONYL)ETHYL]AMINO}METHYL)-2-FURYL]-4-QUINAZOLINAMINE
N-{3-chloro-4-[(3-fluorobenzyl)oxy]phenyl}-6-[5-({[2-(methylsulfonyl)ethyl]amino}methyl)-2-furyl]-4-quinazolinamine
NCGC00167507-01
NSC745750
TL80090051
Tycerb
Tykerb
Tykerb (TN)
Tyverb
UNII-0VUA21238F
lapatinib
lapatinib ditosylate
nchembio866-comp20
30Protein Kinase InhibitorsPhase 2, Early Phase 13689
31Antibodies, MonoclonalPhase 24039
32
LactitolPhase 2336585-86-43871
Synonyms:
4-O-b-D-Galactopyranosyl-D-glucitol, 9CI
E966
Emportal
 
Floralac
Importal
Oponaf
Portolac
33Angiogenesis InhibitorsPhase 2, Phase 14257
34EndostatinsPhase 27371581480
35Angiogenesis Modulating AgentsPhase 2, Phase 14185
36ImmunoglobulinsPhase 26394
37Antifungal AgentsPhase 2, Early Phase 13696
38Antibiotics, AntitubercularPhase 2, Early Phase 17180
39AntibodiesPhase 26394
40Immunosuppressive AgentsPhase 2, Early Phase 113086
41Cyclooxygenase InhibitorsPhase 22870
42Fibrinolytic AgentsPhase 22388
43Platelet Aggregation InhibitorsPhase 22516
44Antirheumatic AgentsPhase 210956
45AntipyreticsPhase 21605
46AnalgesicsPhase 211733
47Analgesics, Non-NarcoticPhase 26501
48Anti-Inflammatory Agents, Non-SteroidalPhase 24443
496-(4-fluorophenyl)-2,3-dihydro-5-(4-pyridinyl)imidazo(2,1-b)thiazolePhase 25
50
Dacarbazineapproved, investigationalPhase 16884342-03-45351166
Synonyms:
(5E)-5-(dimethylaminohydrazinylidene)imidazole-4-carboxamide
(5Z)-5-(dimethylaminohydrazinylidene)imidazole-4-carboxamide
(Dimethyltriazeno)imidazolecarboxamide
37626-23-6
4(5)-(3,3-Dimethyl-1-triazeno)imidazole-4-carboxamide
4(5)-(3,3-Dimethyl-1-triazeno)imidazole-5(4)-carboxamide
4-(3,3-Dimethyl-1-triazeno)imidazole-5-carboxamide
4-(3,3-Dimethyltriazeno)imidazole-5-carboxamide
4-(5)-(3,3-Dimethyl-1-triazeno)imidazole-5(4)-carboxamide
4-(Dimethyltriazeno)imidazole-5-c arboxamide
4-(Dimethyltriazeno)imidazole-5-carboxamide
4-(or 5)-(3,3-Dimethyl-1-triazeno)imidazole-5(or 4)-carboxamide
4-(or 5)-(3,3-Dimethyl-1-triazeno)imidazole-5(or 4)-carboxamide
4-[(1E)-3,3-Dimethyltriaz-1-en-1-yl]-1H-imidazole-5-carboxamide
4-[3,3-dimethyltriaz-1-en-1-yl]-1H-imidazole-5-carboxamide
4342-03-4
5(or 4)-(dimethyltriazeno)imidazol e-4(or 5)-carboxamide
5(or 4)-(dimethyltriazeno)imidazole-4(or 5)-carboxamide
5-(3,3-Dimethyl-1-triazeno)imidazole-4-carboxamide
5-(3,3-Dimethyl-1-triazenyl)-1H-imidazole-4-carboxamide
5-(3,3-Dimethyl-1-triazenyl)imidazole-4-carboxamide
5-(3,3-Dimethyltri azeno)imidazole-4-carboxamide
5-(3,3-Dimethyltriazeno)-imidazole-4-carbamide
5-(3,3-Dimethyltriazeno)imidazole-4-carboxamide
5-(3,3-dimethyltriaz-1-en-1-yl)-1H-imidazole-4-carboxamide
5-(Dimethyltriazeno)-4-imidazolecarboxamide
5-(Dimethyltriazeno)imidazole-4-carboxamide
5-(Dimethyltriazeno)imidazole-4-carboximide
5-(dimethylaminohydrazinylidene)imidazole-4-carboxamide
5-[3,3-Dimethyl-1-triazenyl]imidazole-4-carboxamide
94361-71-4
AC1NQXVV
AC1NS01W
AC1NS4BN
AI3-52825
BPBio1_000428
BRD-K35520305-001-07-8
BSPBio_000388
BSPBio_002091
Biocarbazin
Biocarbazine
Biocarbazine R
C6H10N6O
CAS-891986
CCRIS 190
CHEBI:4305
CHEMBL476
CID5281007
CID5351166
CID5353562
Carboxamide, Dimethyl Imidazole
D00288
D003606
D2390_SIGMA
D3634
DB00851
DIC
DTCI
DTIC
DTIC Dome
DTIC, DTIC-Dome, Dacarbazine
DTIC-Dome
DTICDome
DTIE
Dacarbazin
Dacarbazina
Dacarbazine
Dacarbazine (JAN/USP/INN)
Dacarbazine [USAN:INN:BAN:JAN]
Dacarbazino
Dacarbazino [INN-Spanish]
Dacarbazinum
Dacarbazinum [INN-Latin]
 
Dacatic
Decarbazine
Deticene
Di-me-triazenoimidazolecarboxamide
Di-methyl-triazenoimidazolecarboxamide
Dimethyl Imidazole Carboxamide
Dimethyl Triazeno Imidazole Carboxamide
Dimethyltriazenoimidazolecarboxamide
DivK1c_000326
Dtic-Dome
Dtic-Dome (TN)
Dtic-dome (tn)
EINECS 224-396-1
HE1150000
HMS1569D10
HMS2090A20
HMS2091I20
HMS501A08
HSDB 3219
I06-2280
I14-1659
ICDMT
ICDT
IDI1_000326
Imidazole Carboxamide
Imidazole Carboxamide, Dimethyl
Imidazole carboxamide
KBio1_000326
KBio2_001364
KBio2_003932
KBio2_006500
KBio3_001311
KBioGR_000896
KBioSS_001364
LS-119
MLS001332543
MLS001332544
MolPort-003-666-153
MolPort-003-846-120
MolPort-006-709-420
NCGC00016986-01
NCGC00091861-01
NCGC00091861-02
NCGC00091861-03
NCGC00091861-04
NCI-C04717
NCI60_004053
NCIMech_000261
NINDS_000326
NIOSH/HE1150000
NPFAPI-05
NSC 45388
NSC-45388
NSC45388
Prestwick0_000574
Prestwick1_000574
Prestwick2_000574
Prestwick3_000574
Prestwick_904
S1221_Selleck
SMP2_000251
SMR000857131
SPBio_001075
SPBio_002607
SPECTRUM1500218
ST51014976
Spectrum2_001148
Spectrum3_000366
Spectrum4_000308
Spectrum5_000823
Spectrum_000884
UNII-7GR28W0FJI
WLN: T5M CNJ DVZ ENUNN1&1
dacarbazine

Interventional clinical trials:

(show top 50)    (show all 54)
idNameStatusNCT IDPhase
1Gentamicin Treatment Prior to Schwannoma Surgery - Residual FunctionRecruitingNCT02379754Phase 4
2Gentamicin Treatment Prior to Schwannoma Surgery - No Residual FunctionRecruitingNCT02415257Phase 4
3Stereotactic Radiation in Vestibular SchwannomaUnknown statusNCT01449604Phase 3
4Corticosteroids in Prevention of Facial Palsy After Cranial Base SurgeryCompletedNCT00438087Phase 3
5Vestibular Schwannoma - Radiosurgery or Expectation: V-REX.RecruitingNCT02249572Phase 2, Phase 3
6Cyberknife Radiosurgery for Patients With NeurinomasRecruitingNCT02055859Phase 3
7Bevacizumab for Symptomatic Vestibular Schwannoma in Neurofibromatosis Type 2 (NF2)CompletedNCT01207687Phase 2
8Efficacy and Safety Study of RAD001 in the Growth of the Vestibular Schwannoma(s) in Neurofibromatosis 2 (NF2) PatientsCompletedNCT01490476Phase 2
9Endostatin Study for Patients With Neurofibromatosis Type 2 (NF2) and NF2-Related TumorsCompletedNCT02104323Phase 2
10Lapatinib Study for Children and Adults With Neurofibromatosis Type 2 (NF2) and NF2-Related TumorsCompletedNCT00973739Phase 2
11Phase II Study of the Multichannel Auditory Brain Stem Implant for Deafness Following Surgery for Neurofibromatosis 2CompletedNCT00004437Phase 2
12Phase II Study of Everolimus (RAD001) in Children and Adults With Neurofibromatosis Type 2CompletedNCT01419639Phase 2
13Study of RAD001 for Treatment of NF2-related Vestibular SchwannomaRecruitingNCT01345136Phase 2
14Hearing Outcomes Using Fractionated Proton Radiation Therapy for Vestibular SchwannomaRecruitingNCT01199978Phase 2
15Study of Axitinib in Patients With Neurofibromatosis Type 2 and Progressive Vestibular SchwannomasRecruitingNCT02129647Phase 2
16Trial of Selumetinib in Patients With Neurofibromatosis Type II Related TumorsRecruitingNCT03095248Phase 2
17Icotinib Study for Patients With Neurofibromatosis Type 2 (NF2) and NF2-Related TumorsRecruitingNCT02934256Phase 2
18AZD2014 In NF2 Patients With Progressive or Symptomatic MeningiomasRecruitingNCT02831257Phase 2
19Phase 2 Study of Bevacizumab in Children and Young Adults With NF 2 and Progressive Vestibular SchwannomasActive, not recruitingNCT01767792Phase 2
20Bevacizumab in Treating Patients With Recurrent or Progressive MeningiomasActive, not recruitingNCT01125046Phase 2
21Study of Aspirin in Patients With Vestibular SchwannomaNot yet recruitingNCT03079999Phase 2
22PTC299 for Treatment of Neurofibromatosis Type 2SuspendedNCT00911248Phase 2
23A Study of Nilotinib in Growing Vestibular SchwannomasTerminatedNCT01201538Phase 2
24RO4929097, Temozolomide, and Radiation Therapy in Treating Patients With Newly Diagnosed Malignant GliomaCompletedNCT01119599Phase 1
25An Implant for Hearing Loss Due to Removal of Neurofibromatosis 2 TumorsCompletedNCT00030043Phase 1
26Super-Selective Intraarterial Cerebral Infusion of Bevacizumab (Avastin) for Treatment of Vestibular SchwannomaSuspendedNCT01083966Phase 1
27Vestibular Schwannoma and Psychological FactorsUnknown statusNCT01743248
28Concentration and Activity of Lapatinib in Vestibular SchwannomasUnknown statusNCT00863122Early Phase 1
29Effect of Implant Position on Magnetic Resonance Image DistortionUnknown statusNCT02246231
30Taste Disorders in Middle Ear Disease and After Middle Ear SurgeryUnknown statusNCT01584011
31NF2 Natural History ConsortiumUnknown statusNCT00004483
32Vertigo Perception and Quality of Life in Patients After Surgical Treatment of Vestibular SchwannomaCompletedNCT02963896
33Using Positron Emission Tomography to Predict Intracranial Tumor Growth in Neurofibromatosis Type II PatientsCompletedNCT01222728
34A Case-Referent Study of Brain Tumors in AdultsCompletedNCT00339300
35A Family Study of Adults With GliomaCompletedNCT00339352
36Recovery of Visual Acuity in People With Vestibular DeficitsCompletedNCT00411216
37Vasopressin and V2 Receptor in Meniere's DiseaseCompletedNCT00599560
38Resiliency Training for Patients With Neurofibromatosis Via Videoconferencing With SkypeCompletedNCT02298270
39Gamma Knife Radiosurgery vs Initial Conservative Treatment for Vestibular Schwannoma Patients With Preserved Hearing, a Prospective Randomized StudyRecruitingNCT01938677
40Preoperative Vestibular Rehabilitation Effectiveness After Vestibular Schwannoma SurgeryRecruitingNCT02275325
41Subtotal Resection of Large Acoustic Neuromas With Possible Stereotactic Radiation TherapyRecruitingNCT01129687
42Exploratory Evaluation of AR-42 Histone Deacetylase Inhibitor in the Treatment of Vestibular Schwannoma and MeningiomaRecruitingNCT02282917Early Phase 1
43Exploring the Activity of RAD001 in Vestibular Schwannomas and MeningiomasRecruitingNCT01880749Early Phase 1
44Resiliency Training for Patients With NF2 Via Videoconferencing With SkypeRecruitingNCT02811718
45Familial Investigations of Childhood Cancer PredispositionRecruitingNCT03050268
46Neurofibromatosis (NF) Registry PortalRecruitingNCT01885767
47Cochlear Implantation After Labyrinthectomy or a Translabyrinthine Surgical ApproachActive, not recruitingNCT02309099
48Natural History Study of Patients With Neurofibromatosis Type 2Active, not recruitingNCT00598351
49Evaluating the Pre-Positioning Frame for Robotic Acoustic Neuroma Removal SurgeryNot yet recruitingNCT03057678
50Auditory Nerve Monitoring Using Intra-cochlear Stimulation in Subjects With Acoustic NeuromaNot yet recruitingNCT02948790

Search NIH Clinical Center for Acoustic Neuroma


Cochrane evidence based reviews: neuroma, acoustic

Genetic Tests for Acoustic Neuroma

About this section

Genetic tests related to Acoustic Neuroma:

id Genetic test Affiliating Genes
1 Vestibular Schwannoma27

Anatomical Context for Acoustic Neuroma

About this section

MalaCards organs/tissues related to Acoustic Neuroma:

36
Brain, Testes, Bone, Temporal lobe, Pituitary, Lung, Eye

Publications for Acoustic Neuroma

About this section

Articles related to Acoustic Neuroma:

(show top 50)    (show all 571)
idTitleAuthorsYear
1
Acoustic neuroma as first sign of inner ear functional disorders. (27935543)
2016
2
Evolution of Patients With Immediate Complete Facial Paralysis Secondary to Acoustic Neuroma Surgery. (26719351)
2016
3
Suspected Acoustic Neuroma Demyelinating Lesions. (28005807)
2016
4
The Fully Endoscopic Acoustic Neuroma Surgery. (27565388)
2016
5
SU-F-T-611: Critical Analysis and Efficacy of Linac Based (Beam Modulator) and Cyberknife Treatment Plans for Acoustic Neuroma/schwannoma. (28047111)
2016
6
Acoustic Neuroma Mimicking Orofacial Pain: A Unique Case Report. (28053796)
2016
7
The Persistence of Tinnitus after Acoustic Neuroma Surgery. (27095048)
2016
8
In vivo visualization of the facial nerve in patients with acoustic neuroma using diffusion tensor imaging-based fiber tracking. (26722859)
2016
9
Risk Factors of Acoustic Neuroma: Systematic Review and Meta-Analysis. (26996581)
2016
10
Change in tinnitus after acoustic neuroma removal using a translabyrinthine approach. A Prospective study. (27067182)
2016
11
Surgical treatment of acoustic neuroma: Outcomes and indications. (27330426)
2016
12
Dorsal displacement of the facial nerve in acoustic neuroma surgery: clinical features and surgical outcomes of 21 consecutive dorsal pattern cases. (26621676)
2016
13
Multifactor Influences of Shared Decision-Making in Acoustic Neuroma Treatment. (27930442)
2016
14
SU-F-T-612: Investigation of Acoustic Neuroma Planning for Stereotactic Radiosurgery Utilizing Linac-Based Cone Collimators. (28046447)
2016
15
Suspected Acoustic Neuroma Demyelinating Lesions. (27579562)
2016
16
Unilateral acoustic neuromas in childhood without evidence of neurofibromatosis: experience in 10 patients at a single institute. (27593791)
2015
17
Auditory Pathway Features Determined by DTI in Subjects with Unilateral Acoustic Neuroma. (25813527)
2015
18
Life-threatening posterior fossa cyst induced by pseudomeningocele after operation for acoustic neuroma. (25883852)
2015
19
Fat graft-assisted internal auditory canal closure after retrosigmoid transmeatal resection of acoustic neuroma: Technique for prevention of cerebrospinal fluid leakage. (26482457)
2015
20
Chronic balance disorders after acoustic neuroma surgery: assessment of gravitational vertical perception. (25748558)
2015
21
Quality of life in acoustic neuroma patients. (25473957)
2015
22
Impact of Elevation of Temporal Lobe During Middle Fossa Acoustic Neuroma Surgery on Contralateral Speech Discrimination. (26536414)
2015
23
Acoustic neuroma manifesting as toothache and numbness. (25625716)
2015
24
When is an acoustic neuroma not an acoustic neuroma? Pitfalls for radiosurgeons. (26041515)
2015
25
Facial Nerve Outcome and Tumor Control Rate as a Function of Degree of Resection in Treatment of Large Acoustic Neuromas: Preliminary Report of the Acoustic Neuroma Subtotal Resection Study. (26645964)
2015
26
Self-reported symptoms and patient experience: A British Acoustic Neuroma Association survey. (26523744)
2015
27
Otologic manifestations of acoustic neuroma. (25578127)
2015
28
Facial reanimation after acoustic neuroma resection: options and timing of intervention. (25958894)
2015
29
Abducens nerve schwannoma in cerebellopontine angle mimicking acoustic neuroma. (25759926)
2015
30
Retrosigmoid Versus Translabyrinthine Approach for Acoustic Neuroma Resection: An Assessment of Complications and Payments in a Longitudinal Administrative Database. (26623224)
2015
31
Electroacupuncture therapy for abducent palsy after acoustic neuroma surgery. (25739636)
2015
32
Retrosigmoid versus translabyrinthine approach to acoustic neuroma resection: A comparative cost-effectiveness analysis. (26490680)
2015
33
Risk Factors for Postoperative Cerebral Vasospasm After Surgical Resection of Acoustic Neuroma. (26187110)
2015
34
Tinnitus following treatment for sporadic Acoustic neuroma. (26403598)
2015
35
Preoperative Lumbar Drain Use During Acoustic Neuroma Surgery and Effect on CSF Leak Incidence. (26239000)
2015
36
The changing face of acoustic neuroma management in the USA: Analysis of the 1998 and 2008 patient surveys from the acoustic neuroma association. (23869572)
2014
37
Facial neuroma masquerading as acoustic neuroma. (24775608)
2014
38
Protection of Facial Nerves During Acoustic Neuroma Surgery. (25420533)
2014
39
Magnetic Resonance Spectroscopy Features of Heschl's Gyri in Patients with Unilateral Acoustic Neuroma: Preliminary Study. (25172413)
2014
40
Improved preservation of function during acoustic neuroma surgery. (25343177)
2014
41
Long-term mobile phone use and acoustic neuroma. (25076157)
2014
42
Acoustic neuroma: An investigation of associations between tumor size and diagnostic delays, facial weakness, and surgical complications. (25181660)
2014
43
Loud noise exposure and acoustic neuroma. (24786799)
2014
44
What is the best method to treat CSF leaks following resection of an acoustic neuroma? (25263342)
2014
45
Retractorless translabyrinthine approach for resection of a large acoustic neuroma: operative video and technical nuances. (24380514)
2014
46
Validation of self-reported start year of mobile phone use in a Swedish case-control study on radiofrequency fields and acoustic neuroma risk. (25352163)
2014
47
Acoustic neuroma: potential risk factors and audiometric surveillance in the aluminium industry. (25015928)
2014
48
Retrosigmoid removal of small acoustic neuroma: curative tumor removal with preservation of function. (24995779)
2014
49
Long-term Mobile Phone Use and Acoustic Neuroma Risk. (24434752)
2014
50
A United Kingdom Survey of Concerns, Needs, and Priorities Reported by Patients Diagnosed With Acoustic Neuroma. (25118579)
2014

Variations for Acoustic Neuroma

About this section

Expression for genes affiliated with Acoustic Neuroma

About this section
Search GEO for disease gene expression data for Acoustic Neuroma.

Pathways for genes affiliated with Acoustic Neuroma

About this section

Pathways related to Acoustic Neuroma according to GeneCards Suite gene sharing:

idSuper pathwaysScoreTop Affiliating Genes
19.7NBN, PCNA
29.5AQP1, AQP4, TGFB1
3
Show member pathways
8.8LIG1, MSH2, PCNA
48.6MGMT, MSH2, NBN, PCNA
5
Show member pathways
8.5ERCC5, MGMT, MSH2, PCNA
6
Show member pathways
8.4ERCC5, LIG1, PARP1, PCNA
7
Show member pathways
8.4ERCC5, LIG1, PARP1, PCNA
8
Show member pathways
6.9ERCC5, LIG1, MGMT, MSH2, NBN, PARP1
9
Show member pathways
6.9ERCC5, LIG1, MGMT, MSH2, NBN, PARP1

GO Terms for genes affiliated with Acoustic Neuroma

About this section

Cellular components related to Acoustic Neuroma according to GeneCards Suite gene sharing:

idNameGO IDScoreTop Affiliating Genes
1replication forkGO:00056579.7NBN, PCNA
2nuclear chromosome, telomeric regionGO:00007849.7MSH2, NBN, PARP1, PCNA
3nucleoplasmGO:00056547.3ERCC5, LIG1, MGMT, MSH2, NBN, PARP1
4nucleusGO:00056346.1AQP1, ERCC5, LIG1, MGMT, MSH2, NBN

Biological processes related to Acoustic Neuroma according to GeneCards Suite gene sharing:

(show all 36)
idNameGO IDScoreTop Affiliating Genes
1cell-cell junction organizationGO:004521610.7NF2, TGFB1
2cellular response to dexamethasone stimulusGO:007154910.7AQP1, TGFB1
3lens fiber cell differentiationGO:007030610.6NF2, TGFB1
4negative regulation of cell-cell adhesionGO:002240810.6NF2, TGFB1
5negative regulation of DNA replicationGO:000815610.6NF2, TGFB1
6liver regenerationGO:009742110.6PCNA, TGFB1
7DNA damage response, detection of DNA damageGO:004276910.5PARP1, PCNA
8positive regulation of protein localization to nucleusGO:190018210.5PARP1, TGFB1
9positive regulation of SMAD protein import into nucleusGO:006039110.5PARP1, TGFB1
10positive regulation of transcription regulatory region DNA bindingGO:200067910.5PARP1, TGFB1
11mitotic cell cycle checkpointGO:000709310.5NBN, TGFB1
12multicellular organismal water homeostasisGO:005089110.4AQP1, AQP4
13renal water homeostasisGO:000309110.4AQP1, AQP4
14negative regulation of telomere maintenance via telomere lengtheningGO:190435710.4NBN, PARP1
15positive regulation of isotype switching to IgA isotypesGO:004829810.3MSH2, TGFB1
16cellular response to ionizing radiationGO:007147910.3MGMT, TGFB1
17nucleotide-excision repair, DNA incision, 3-to lesionGO:000629510.3ERCC5, PARP1
18nucleotide-excision repair, preincision complex assemblyGO:000629410.2ERCC5, PARP1
19nucleotide-excision repair, preincision complex stabilizationGO:000629310.2ERCC5, PARP1
20isotype switchingGO:004519010.2MSH2, NBN
21positive regulation of DNA repairGO:004573910.2MGMT, PCNA
22cell cycle arrestGO:000705010.0MSH2, NBN, TGFB1
23nucleotide-excision repair, DNA gap fillingGO:000629710.0LIG1, PCNA
24DNA ligation involved in DNA repairGO:005110310.0LIG1, PARP1
25nucleotide-excision repair, DNA incisionGO:00336839.9ERCC5, PARP1, PCNA
26nucleotide-excision repair, DNA incision, 5-to lesionGO:00062969.9ERCC5, PARP1, PCNA
27telomere maintenanceGO:00007239.9NBN, PARP1, PCNA
28double-strand break repairGO:00063029.9MSH2, NBN, PARP1
29water transportGO:00068339.7AQP1, AQP4
30DNA replicationGO:00062609.6LIG1, NBN, PCNA
31response to drugGO:00424939.6ABCA2, AQP1, MGMT, TGFB1
32mismatch repairGO:00062989.5LIG1, MSH2, PCNA
33DNA ligationGO:00062669.4LIG1, MGMT, PCNA
34transcription-coupled nucleotide-excision repairGO:00062839.1ERCC5, LIG1, PCNA
35cellular response to DNA damage stimulusGO:00069747.6ERCC5, LIG1, MGMT, MSH2, NBN, PARP1
36DNA repairGO:00062817.6ERCC5, LIG1, MGMT, MSH2, NBN, PARP1

Molecular functions related to Acoustic Neuroma according to GeneCards Suite gene sharing:

(show all 10)
idNameGO IDScoreTop Affiliating Genes
1dinucleotide insertion or deletion bindingGO:003213910.4MSH2, PCNA
2MutLalpha complex bindingGO:003240510.3MSH2, PCNA
3damaged DNA bindingGO:000368410.0MSH2, NBN, PCNA
4DNA ligase (ATP) activityGO:000391010.0LIG1, PARP1
5water channel activityGO:00152509.9AQP1, AQP4
6transporter activityGO:00052159.8ABCA2, AQP1, AQP4
7water transmembrane transporter activityGO:00053729.7AQP1, AQP4
8enzyme bindingGO:00198999.6MSH2, PARP1, PCNA, TGFB1
9protein N-terminus bindingGO:00474859.5ERCC5, NBN, PARP1, TGFB1
10DNA bindingGO:00036777.6ERCC5, LIG1, MGMT, MSH2, PARP1, PCNA

Sources for Acoustic Neuroma

About this section
2CDC
6CNVD
10DGIdb
15ExPASy
16FDA
17FMA
27GTR
28HGMD
29HMDB
30ICD10
31ICD10 via Orphanet
32ICD9CM
33IUPHAR
34KEGG
37MedGen
39MeSH
40MESH via Orphanet
41MGI
44NCI
45NCIt
46NDF-RT
49NINDS
50Novoseek
52OMIM
53OMIM via Orphanet
57PubMed
58QIAGEN
63SNOMED-CT via Orphanet
67Tumor Gene Family of Databases
68UMLS
69UMLS via Orphanet